By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences has completed the sales of its RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5 million in cash.

The divestiture, announced a couple of weeks ago, also includes Biotage assuming liabilities of about $500,000 associated with the products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.